Key considerations & development of regulatory guidance in CMC

Cell & Gene Therapy Insights 2022; 9(3), 327–333

DOI: 10.18609/cgti.2023.051

Published: 11 April 2023
David Ordóñez del Valle

David McCall, Senior Editor, BioInsights, speaks to (pictured) David Ordóñez del Valle, a Quality Assessor in the Biological Products Division of the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)